184 related articles for article (PubMed ID: 30487734)
1. Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation.
Lasorsa A; Malki I; Cantrelle FX; Merzougui H; Boll E; Lambert JC; Landrieu I
Front Mol Neurosci; 2018; 11():421. PubMed ID: 30487734
[TBL] [Abstract][Full Text] [Related]
2. Conformation and Affinity Modulations by Multiple Phosphorylation Occurring in the BIN1 SH3 Domain Binding Site of the Tau Protein Proline-Rich Region.
Lasorsa A; Bera K; Malki I; Dupré E; Cantrelle FX; Merzougui H; Sinnaeve D; Hanoulle X; Hritz J; Landrieu I
Biochemistry; 2023 Jun; 62(11):1631-1642. PubMed ID: 37167199
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
[TBL] [Abstract][Full Text] [Related]
4. Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain.
Sottejeau Y; Bretteville A; Cantrelle FX; Malmanche N; Demiaute F; Mendes T; Delay C; Alves Dos Alves H; Flaig A; Davies P; Dourlen P; Dermaut B; Laporte J; Amouyel P; Lippens G; Chapuis J; Landrieu I; Lambert JC
Acta Neuropathol Commun; 2015 Sep; 3():58. PubMed ID: 26395440
[TBL] [Abstract][Full Text] [Related]
5. Bridging Integrator-1 protein loss in Alzheimer's disease promotes synaptic tau accumulation and disrupts tau release.
Glennon EB; Lau DH; Gabriele RMC; Taylor MF; Troakes C; Opie-Martin S; Elliott C; Killick R; Hanger DP; Perez-Nievas BG; Noble W
Brain Commun; 2020; 2(1):. PubMed ID: 32500121
[TBL] [Abstract][Full Text] [Related]
6. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
[TBL] [Abstract][Full Text] [Related]
7. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
[TBL] [Abstract][Full Text] [Related]
8. Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay.
Wang X; Chang C; Wang D; Hong S
J Mol Graph Model; 2019 Jul; 90():265-272. PubMed ID: 31112821
[TBL] [Abstract][Full Text] [Related]
9. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
10. BIN1 membrane curvature sensing and generation show autoinhibition regulated by downstream ligands and PI(4,5)P2.
Wu T; Baumgart T
Biochemistry; 2014 Nov; 53(46):7297-309. PubMed ID: 25350771
[TBL] [Abstract][Full Text] [Related]
11. Exploring the systematic effect of N-substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation.
Fu Y; He P; Zhou Y; Huang S; Liang L; Liu S
Proteins; 2019 Nov; 87(11):979-991. PubMed ID: 31197859
[TBL] [Abstract][Full Text] [Related]
12. Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.
Rani L; Mittal J; Mallajosyula SS
J Phys Chem B; 2020 Mar; 124(10):1909-1918. PubMed ID: 32065850
[TBL] [Abstract][Full Text] [Related]
13. Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current.
Jos S; Poulose R; Kambaru A; Gogoi H; Dalavaikodihalli Nanjaiah N; Padmanabhan B; Mehta B; Padavattan S
J Mol Biol; 2024 Feb; 436(4):168445. PubMed ID: 38218365
[TBL] [Abstract][Full Text] [Related]
14. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
Thomas S; Hoxha K; Tran A; Prendergast GC
J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
[TBL] [Abstract][Full Text] [Related]
15. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
[TBL] [Abstract][Full Text] [Related]
16. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55.
Kang H; Freund C; Duke-Cohan JS; Musacchio A; Wagner G; Rudd CE
EMBO J; 2000 Jun; 19(12):2889-99. PubMed ID: 10856234
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Bin1 SH3 domain binding by phosphoinositides.
Kojima C; Hashimoto A; Yabuta I; Hirose M; Hashimoto S; Kanaho Y; Sumimoto H; Ikegami T; Sabe H
EMBO J; 2004 Nov; 23(22):4413-22. PubMed ID: 15483625
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus NS5A is able to competitively displace c-Myc from the Bin1 SH3 domain in vitro.
Aladag A; Hoffmann S; Stoldt M; Bösing C; Willbold D; Schwarten M
J Pept Sci; 2014 May; 20(5):334-40. PubMed ID: 24616074
[TBL] [Abstract][Full Text] [Related]
19. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
20. The SH3 domain of Caskin1 binds to lysophosphatidic acid suggesting a direct role for the lipid in intracellular signaling.
Koprivanacz K; Tőke O; Besztercei B; Juhász T; Radnai L; Merő B; Mihály J; Péter M; Balogh G; Vígh L; Buday L; Liliom K
Cell Signal; 2017 Apr; 32():66-75. PubMed ID: 28104445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
